FDA will convene a one-day, in-person and virtual public workshop, “Improving Anaphylaxis Outcomes: Approaches for Enhancing Access to Epinephrine ,” on Tuesday, Dec. 16, 2025 (1). The workshop is ...

Positive Regulatory Response Marks Important Milestone for NS002 Development ProgramTEL AVIV, Nov. 06, 2025 (GLOBE NEWSWIRE) ...

Canadian Medical Association Journal article warns against relying on less effective treatments for anaphylaxis ...

Offers no-hassle, free virtual visit with healthcare provider for patients to receive neffy for $0 co-pay if eligible with ...

Ustekinumab had a market value of approximately $17.1 billion for the 12 months ending December 2024, per IQVIA.

$32.5 million in revenue, including $31.3 million in neffy U.S. net product revenue in third quarter of 2025 Continued U.S. product growth driven by direct-to-consumer (DTC) investments and real-world ...

ORLANDO -- Non-injection routes of epinephrine delivery are gaining proponents for rapid response to immunotherapy anaphylaxis in the allergists' office. "I was pretty shocked the first time I used it ...

Despite his best effort to check food labels, one college student details his close call with anaphylaxis and what he learned from it.